Breast Cancer Campaign’s third Scientific Conference

MEDIA ALERT Breast Cancer Campaign’s third Scientific Conference - Breast Cancer Research 2010 Breast Cancer Campaign’s third scientific conference takes place at the Royal Society, London, on 18 May 2010. The conference programme reflects the wide reaching research funded by the charity and the abundance of talent in the breast cancer research field. Among the highlights are three of the charity’s Fellows: • Dr Gillian Farnie, University of Manchester, ‘Targeting breast cancer stem cells to overcome resistance to radiotherapy and chemotherapy’ • Dr James Flanagan, Imperial College London, ‘New ways to identify people at risk of inherited breast cancer’ • Dr Jo Morris, King’s College London, ‘Understanding the roles of SUMO and BRCA1 molecules in DNA repair’ Keynote topics: • Professor Robert Coleman, Weston Park Hospital, Sheffield, ‘Recent advances in treatment of metastatic breast cancer’ • Professor John Bartlett, University of Edinburgh, ‘New biomarkers for the diagnosis and prediction of treatment response in clinical breast cancer’ For media enquiries please contact Claire Learner, Media Relations Officer, 020 7749 3705, 07736 313698, clearner@breastcancercampaign.org Ends Notes to editors • Breast Cancer Campaign aims to beat breast cancer by funding innovative world-class research to understand how breast cancer develops, leading to improved diagnosis, treatment, prevention and cure • Currently it supports 114 research projects, worth £17 million, in 40 centres of excellence across the UK and Ireland • Breast cancer is the most common cancer in the UK and accounts for nearly one in three of all cancers in women • In the UK, nearly 46,000 new cases of breast cancer are diagnosed each year - that’s 125 a day • Visit www.breastcancercampaign.org • Read Chief Executive Pamela Goldberg’s blog http://pamelagoldbergblog.blogspot.com/